Gentilcore Douglas J
SEC insider (Form 3/4/5 filer). CIK 0002052524. SVP, Danyelza Bus. Unit Head at Y-mAbs Therapeutics, Inc. (YMAB). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2025. Located in NEW YORK, NY.
Companies Gentilcore Douglas J has filed insider reports for
- Y-mAbs Therapeutics, Inc. (YMAB): Officer, SVP, Danyelza Bus. Unit Head
Gentilcore Douglas J
CIK: 0002052524
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
YMAB
Y-mAbs Therapeutics, Inc.
Officer